By Kelly Lienhard ( December 12, 2023, 6:10 PM EST) -- Novartis Pharmaceuticals has agreed to pay $182 million to Daiichi Sankyo subsidiary Plexxikon as part of a settlement in a patent infringement case over skin cancer drug Tafinlar after Novartis appealed a 2022 decision awarding Plexxikon $177.8 million, plus royalties....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.